Coronary Cutting Balloon Market Size - By Number of Blades, By Application, By End Use & Forecast, 2025 - 2034

Coronary Cutting Balloon Market Size

The global coronary cutting balloon market size was valued at USD 141.1 million in 2024 and is anticipated to reach USD 395.6 million by 2034, growing at a CAGR of 9.8% from 2025 to 2034. High market growth is primarily attributed to rising technological advancements, increasing prevalence of cardiovascular diseases, and growing adoption of minimally invasive cardiovascular procedures among other factors.
 

The rising prevalence of coronary artery disease (CAD) is significantly driving the growth of the coronary cutting balloon market. For instance, according to the data reported by Journals of American College of Cardiology (JACC), around 315 million prevalent cases of CAD were recorded worldwide in 2022. The patient population is fueled by a growing diabetic population, rise in number of people suffering from hypertension, coupled with sedentary lifestyle and poor dietary habits among other pointers resulting in accumulation of atherosclerotic plaques that narrow or block coronary arteries. Cutting balloons are particularly effective in treating calcified and resistant lesions commonly seen in CAD. As the number of CAD-related interventions grows globally, the demand for cutting balloons as a precise and reliable plaque-modification tool continues to rise in clinical practice.
 

The demand for coronary cutting balloons is growing due to the increased prevalence of cardiovascular diseases and the more advanced diagnostic methods like coronary angiography and intravascular imaging. The ability to accurately identify intricate lesions early on allows for timely intervention with cutting balloons, enhancing their treatment effectiveness and increasing their use in both developed and developing economies.
 

These devices treat coronary artery disease (CAD) by altering atherosclerotic deposits within the coronary arteries. The devices integrate a standard balloon catheter with microsurgical blades (atherotomes) that during inflation incise the vessel wall, thus allowing lesion dilation in a safer manner especially in multifaceted lesions.
 

Coronary Cutting Balloon Market Trends

• Growing awareness levels, preference for minimally invasive procedures among various other ongoing trends is expected to fuel the industry growth over the forecast timeframe.
   
• One of the key trends is an increase in preference for lesion preparation methods prior to stent deployment, especially in more challenging or calcified lesions. This also improves stent expansion and long-term outcomes. Cutting balloons is becoming popular because they make controlled and precise cuts through resistant plaque.
   
• Additionally, lower profile cutting balloons that are semi-compliant and non-compliant offer better deliverability and modification of plaque. Further, the emergence of drug-coated balloons in the market are aimed at dealing with restenosis after cutting balloon procedures to help boost efficacy.
   
• The market is being influenced by shifts towards less invasive options since both patients seeking care and healthcare workers prefer those methods that do not require lengthy recovery periods. Emerging economies coupled with increased investment and financing for infrastructure development in interventional cardiology along with active involvement in cardiovascular screening programs is increasing procedural volumes.
   

Coronary Cutting Balloon Market Analysis

Based on the number of blades, the global market is segmented into three blades and four blades. The three blades segment exceeded USD 88 million in 2024.
 

• The three-blade devices offer a balance between effective plaque modification and ease of deliverability, making them suitable for a broad range of coronary lesions, including moderately calcified and fibrotic plaques. Their simpler design compared to four-blade models allows for improved flexibility and cross ability, especially in tortuous vascular anatomy, which is critical in percutaneous coronary interventions (PCI).
   
• Additionally, three-blade cutting balloons are generally favored in cases where lesion scoring is required with minimal vessel alteration to decrease the chances of complications such as vessel dissection. With primary stenting and managing in-stent restenosis, there has been increasing emphasis by interventional cardiologists on optimal lesion preparation to ensure proper stent placement.
   
• Further, owing to their established clinical value and alignment with current practices in catheterization laboratories, there is expected to be a consistent demand for three-blade cutting balloons especially in cardiac centers and hospitals around the globe.
   

In 2021, the global coronary cutting balloon market was valued at USD 46.7 million. The following year, it saw a slight increase to USD 73.2 million, and by 2023, the market further climbed to USD 106 million. Based on application, the market is categorized into calcified lesion treatment, in-stent restenosis, and lesion preparation. The calcified lesion treatment segment accounted for leading share in the market in 2024 and is expected to reach around USD 229.3 million by 2034.
 

• The treatment for calcified lesions stands out as a significant area of focus driving growth within the coronary cutting balloon market due to rising prevalence of severely calcified coronary artery disease, especially in older adults and in people with diabetes.
   
• Cutting balloons equipped with microsurgical blades enable controlled enhancement of plaque incisions, thus improving compliance among lesions and enabling safer deployment of stents during procedures.
   
• Moreover, as interventional cardiologists manage increasing volumes of intricate PCI cases, there is a heightened clinical demand for effective preparation tools, that have fostered worldwide adoption of cutting balloons.
   
• In addition, recent advancements in imaging such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) enhance visualization for the detection of calcified lesions which strengthens their case for tailored intervention. Therefore, alongside favorable clinical outcomes from their use and increasing understanding of cutting balloon’s effectiveness in this role, this segment will continue to experience robust global demand.
   

Based on end use, the global coronary cutting balloon market is classified into hospitals, catheterization laboratories, ambulatory surgical centers, and other end users. In 2024, the hospitals segment held highest market share and is expected to showcase significant growth over the analysis period.

• The ability to perform complex cardiovascular procedures makes hospitals the preferred end-users of coronary cutting balloons. With advanced Cath labs and trained interventional cardiologists, hospital settings serve as the primary centers for performing PCIs.
   
• Further, multidisciplinary cardiac care teams as well as 24-hour services provide additional preferences to hospital settings. Patients suffering from severe or more complicated forms of coronary artery disease also require aid in lesion preparation so that cutting balloons can be used effectively during stent deployment.
   
• Moreover, contributing to this trend is the increasing global prevalence of coronary artery diseases alongside increased healthcare expenditure at urban and tertiary level hospitals. This makes them critical growth drivers for the overall market.
   

The North America coronary cutting balloon market accounted for leading share and was valued at USD 69.5 million in 2024. Favorable reimbursement policies, coupled with rise in awareness levels and increasing prevalence of coronary artery disease (CAD) are expected to drive regional growth.
 

The U.S. coronary cutting balloon market was valued at USD 21.5 million and USD 33.6 million in 2021 and 2022, respectively. The market size reached USD 64.4 million in 2024, growing from USD 48.5 million in 2023.
 

• The U.S. leads in the utilization of cutting balloons for coronary surgery given the high patient population for CAD condition, extensive presence of advanced cardiac centers, and early industry innovation adoption.
   
• Surging procedural rates of PCI coupled with the well-funded reimbursement structure of the U.S. drives its persistent need for the cutting balloons particular on cases with calcified lesions as well as in-stent restenosis.
   
• Moreover, apart from these factors, continuous novel product innovation by Boston Scientific guarantees continuous product supply whereas adoption of IVUS/OCT helps further in defining complicated lesions where cutting balloons are beneficial.
   

Europe coronary cutting balloon market accounted for significant revenue share and was valued at around USD 43.2 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Factors such as the substantial percentage of geriatric population, increasing prevalence of chronic health conditions such as hypertension and diabetes, as well as higher adoption rates of precision-based coronary interventions are shaping the market growth. Regional countries such as Germany, France, and Italy have well-developed interventional cardiology programs and are utilizing cutting balloon technology for lesion preparation with increasing adoption rate. 
   
• Further, the clinical endorsement of pre-dilatation methods along with drug-coated cutting balloon technologies is improving outcomes which in turn drives demand.
   
• Additionally, training initiatives focusing on procedural innovation alongside transnational research collaborations within EU countries also improve procedural volumes.
   

The UK coronary cutting balloon market is expected to witness considerable growth over the analysis period.
 

• The older and diabetic populations in the UK are particularly affected by cardiovascular diseases such as coronary artery disease. This has resulted in a demand for cardiac surgeries, where the NHS is focusing on less invasive procedures which may open new avenues for the adoption of coronary cutting balloons in the country.
   
• Additionally, as the country remains more price-sensitive, the increasing availability of catheterization labs and centralized purchasing through NHS frameworks has enhanced device supply access.
   
• In addition to these factors, ongoing clinical studies along with the country’s centers of excellence in cardiovascular medicine stimulate further business opportunities.
   

The Asia Pacific coronary cutting balloon market is anticipated to grow at the highest CAGR of 11.1% during the analysis timeframe.
 

• Asia Pacific is experiencing increased growth owing to an expanding patient base with CAD, along with greater healthcare spending and awareness. Countries such as India, China, and South Korea are modernizing their cardiac care infrastructure which is facilitating the availability of cutting balloon technologies. 
   
• In addition, conditions including hypertension and diabetes, along with aging population, have increased the demand for coronary surgeries in the region. 
   
• Further, there are affordability issues related to products and procedures in some regional countries; however, public-private partnerships and the proliferation of private hospitals stand to improve penetration rates of cutting balloons in the region.
   

China coronary cutting balloon market is predicted to grow significantly over the forecast period.
 

• In China, the growing prevalence of cardiovascular diseases along with rapid growth of interventional cardiology programs, especially at higher-level urban hospitals, is creating a healthy demand. Government policies implemented to boost healthcare infrastructure and greater availability of sophisticated medical equipment have facilitated the use of cutting balloons in procedures.
   
• Moreover, tourism for healthcare services in major cities and adoption of less invasive cardiovascular surgical techniques are augmenting procedural volumes.
   
• Furthermore, greater availability of devices is being made possible due to partnerships formed between local device manufacturers and foreign companies. Additionally, courses designed to train skilled interventional physicians are playing a key role in the overall product adoption scenario.
   

Coronary Cutting Balloon Market Share

Boston Scientific and LEPU MEDICAL are key participants in the coronary cutting balloon industry which focuses on product innovations, strategic collaborations, and area growth to strengthen their market presence. Firms are utilizing advanced cutting balloon technologies with blade designs vertically propelled by lower crossing profiles to address complex lesions at more acute angles. Other players are combining drug coated technologies with cutting balloons to deal with negative outcomes of in stent restenosis. Partnerships with hospitals or research centers also enable quicker clinical validation and adoption. Moreover, leading manufacturers expand their emerging market reach through distributor partnerships, local regulatory approvals while focusing on training courses for interventional cardiologists and increasing adoption rate for the procedure.
 

Coronary Cutting Balloon Market Companies

Few of the prominent players operating in the coronary cutting balloon industry include:

• Boston Scientific
• LEPU MEDICAL
• SHENQI MEDICAL
   
• Boston Scientific focus on offering novel and innovative products that resulted in the development of devices integrating latest technologies such as WOLVERINE Coronary Cutting Balloon system in the cutting balloon market. The product offers precise plaque modification with controlled dilatation, exceptional deliverability, and proven clinical efficacy, making it a trusted solution for complex and calcified coronary lesions. The company has a wide range of portfolio covering both coronary and peripheral indications.
   

Coronary Cutting Balloon Industry News

• In June 2023, Boston Scientific launched its Wolverine Cutting Balloon Dilatation Device in Korea. The device finds its application in percutaneous coronary intervention (PCI) procedures to widen or clear the narrowed coronary arteries. This development may enable the company to improve its product reach and enhance sales prospects in the Korean market.
   

The coronary cutting balloon market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Number of Blades

• Three blades
• Four blades

Market, By Application

• Calcified lesion treatment
• In-stent restenosis
• Lesion preparation

Market, By End Use

• Hospitals
• Catheterization laboratories
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Rest of the world (RoW)